INTELLIA THERAPEUTICS INC revenue breakdown overview

INTELLIA THERAPEUTICS INC revenue for the last year amounted to 55.91 M EUR, the most of which — 55.91 M EUR — came from its highest performing source at the moment, Genome Editing-based Therapies, the year earlier bringing 32.87 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought INTELLIA THERAPEUTICS INC 55.91 M EUR, and the year before that — 32.87 M EUR.